Showing results (471-480 of 753) with videos related to
Sort By:
Pageof 76
Neuro-Oncology|April 27, 2017
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based studyDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.JAMA Oncology|March 17, 2017
Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based StudyAllison M Martin, Daniel N Cagney, Paul J Catalano, et al.Journal of Neuro-Oncology|September 23, 2011
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningiomaDavid A Reardon, Andrew D Norden, Annick Desjardins, et al.Clinical and Translational Radiation Oncology|December 4, 2023
Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrenceSebastian M Christ, Gilbert Youssef, Shyam K Tanguturi, et al.Neurology|February 26, 2026
Primary Motor Cortex Involvement and Its Association With Seizure Risk in Patients With Brain MetastasesClara Baselga-Garriga, Sandeep Purohit, Nayan Lamba, et al.Neuro-Oncology|March 11, 2024
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO groupNorbert Galldiks, Timothy J Kaufmann, Philipp Vollmuth, et al.Neuro-Oncology|January 17, 2019
Molecular and translational advances in meningiomasSuganth Suppiah, Farshad Nassiri, Wenya Linda Bi, et al.Cancer Research|January 5, 2011
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escapeEmmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, et al.The Lancet. Oncology|May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO groupEvanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.Pageof 76